tailieunhanh - Chemically induced mouse liver tumors are resistant to treatment with atorvastatin

Atorvastatin is a potent inhibitor of the mevalonate pathway and widely used as a hypolipidemic drug. Some epidemiological studies and animal experiments indicate that the long-term use of atorvastatin and structurally related drugs might be associated with a reduced risk of developing hepatocellular carcinoma (HCC), the most common hepatocellular malignancy in humans. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN